Upsher-Smith offers help to people with migraines during Migraine Month
Upsher-Smith is continuing to help patients who suffer from migraines during National Migraine & Headache Awareness Month.
Upsher-Smith's Access Pathways Program, which offers patient savings and support services, helps to ensure that every patient can have access to migraine medications.
“There is no question that migraine headaches can be hard to live with and treat and managing migraine during the COVID-19 pandemic is no exception,” said Rusty Field, Upsher-Smith president and CEO. “Upsher-Smith remains committed to keeping its portfolio of migraine products available and affordable during these challenging times.”
Upsher-Smith’s self-administered migraine products include Tosymra (sumatriptan nasal spray) 10 mg and Zembrace SymTouch (sumatriptan) injection 3 mg for the acute treatment of migraine in adults, and Qudexy XR (topiramate) extended-release capsules for the prevention of migraine headaches in adults and adolescents.
Supported by Upsher-Smith’s Access Pathways Program, eligible patients pay $0 Per Prescription for their migraine medication with the Platinum Pass Savings Card.
Commercially insured patients get their first prescription for free, even if a prior authorization is required, and the Platinum PassSavings Card is renewable annually.
Patients can easily activate their Zembrace SymTouch and Tosymra Platinum Pass Savings Card online or by phone. For Zembrace SymTouch, call 1-855-699-6062 or click here and for Tosymra call 1-855-699-6064 or click here.
Patients can call 1-855-282-4887 to request a Platinum Pass for Qudexy XR.